Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells

Kidney International

Volumn 54, Issue 6, 1998, Pages 1985-1998

  Cortes, Pedro ^a   Riser, Bruce L ^a   Asano, Kenichiro ^a   Rodríguez barbero, Alicia ^a   Narins, Robert G ^a   Yee, Jerry ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Collagen metabolism; Diabetic nephropathy; Glomerulosclerosis; Metformin; Sulfonylureas; TGF

Indexed keywords

BIGUANIDE; CARBON 14; COLLAGEN; DEOXYGLUCOSE; FIBRONECTIN; GLUCOSE TRANSPORTER; MESSENGER RNA; METFORMIN; ORAL ANTIDIABETIC AGENT; PROLINE; SULFONYLUREA; TOLAZAMIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; COLLAGEN METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLUCOSE TRANSPORT; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0031783730     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00207.x     Document Type: Article

References (86)

1. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN DM, GOETZ FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1994
2. STEFFES MW, BILOUS RW, SUTHERLAND DER, MAUER SM: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684, 1992
3. AYO SH, RADNIK RA, GARONI JA, GLASS WF II, KREISHERG JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136:1339-1348, 1990
4. AYO SH, RADNIK RA, GLASS WF II, GARONI JA, RAMPT ER, APPLING DR, KREISBERG JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260(Renal Fluid Electrol Physiol 29):F185-F191, 1991
5. NAHMAN NS JR, LEONHART KL, COSIO FG, HEBERT CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 41:396-402, 1992
6. DANNE T, SPIRO MJ, SPIRO RG: Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial and mesangial cells. Diabetes 42:170-177, 1993
7. ZIYADEH FN, SHARMA K, ERICKSEN M, WOLF G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor. J Clin Invest 93:536-542, 1994
8. TAKEUCHI A, THROCKMORTON DC, BROGDEN AP, YOSHIZAWA N, RASMUSSEN H, KASHGARIAN M: Periodic high extracellular glucose enhances production of collagens II and IV by mesangial cells. Am J Physiol 268(Renal Fluid Electrol Physiol 37):F13-F19, 1995
9. BENDING JJ, VIBERTI GC, BILOUS RW, KEEN H: Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria. Diabetes 34(SuppL 3):69-73, 1985
10. FELD-RASMUSSEN B, MATHIESEN ER, JENSEN T, LAURITZEN T, DECKERT T: Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: An update of the Steno studies. Diabetologia 14:164-170, 1991
11. DAHL-JØRGENSEN K, BJØRO T, KIERULF P, SANDVIK L, BANGSTAD JH, HANSSEN KF: Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 41:920-923, 1992
12. THE DIABETES CONTROL, COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
13. REICHARD P, NILSSON B-Y, ROSENQVTST U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
14. BARBOSA J, STEFFES MW, SUTTHERLAND DER, CONNETT JE, RAO KV, MAUER SM: Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients. JAMA 272:600-606, 1994
15. AYO SH, RADNICK R, GARONI JA, TROYER DA, KREISBERG JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261(Renal Fluid Electrol Physiol 30):F571-F577, 1991
16. ZIYADEH FN, SHARMA K, ERICKSEN M, WOLF G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming groth factor-β. J Clin Invest 93:536-542, 1994
17. 1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int 46:1019-1024, 1994
18. KOLM-LITTY V, SAUER U, NERLICH A, LEHMANN R, SCHLEICHER ED: High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-169, 1998
19. PARK I-S, KIYOMOTO H, ABBOUD SL, ABBOUD HE: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
20. SHARMA K, JIN Y, ZIYADEH FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
21. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor β is elevated inhuman and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818
22. GOULD GW, HOLMAN GD: The glucose transporter family: Structure, function and tissue-specific expression. Biochem J 295:329-341, 1993
23. HEILIG CW, ZALOGA C, LEE M, ZHAO X, RISER B, BROSIUS F, CORTES P: Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. Lab Invest 73:674-684, 1995
24. BROSIUS III FC, BRIGGS JP, MARCUS RG, BARAC-NIETO M, CHARRON MJ: Insulin-responsive glucose transporter expression in renal microvessels and glomeruli. Kidney Int 42:1086-1092, 1992
25. HEILIG CW, CONCEPCION LA, RISER BL, FREYTAG SO, ZHU M, CORTES P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814, 1995
26. ARNQVIST HJ, BALLERMAN BJ, KING GL: Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells. Am J Physiol 254(Cell Physiol 23):C411-C416, 1988
27. HANEDA M, KIKKAWA R, TOGAWA M, KOYA D, KAJIWARA N, SHIGETA Y: Metabolic actions of insulin-like growth factor I in cultured glomerular mesangial cells. Metabolism 40:1311-1316, 1991
28. BALDWIN SA: Mammalian passive glucose transporters: Members of a ubiquitous family of active and passive transport proteins. Biochem Biophys Acta 1154:17-49, 1993
29. WANG PH, MOLLER D, FLIER JS, NAYAK RC, SMITH RJ: Coordinate regulation of glucose transporter function, number, and gene expression by insulin an sulfonylureas in L6 rat skeletal muscle cells. J Clin Invest 84:62-67, 1989
30. TORDJMAN KM, LEINGANG KA, JAMES DA, MUECKLER MM: Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: Effect of chronic insulin and tolbutamide treatment. Proc Natl Acad Sci USA 86:7761-7765, 1989
31. MATTHAEI S, HAMANN A, KLEIN HH, BENECKE H, KREYMAN G, FLIER JF, GRETEN H: Association of metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes 40:850-857, 1991
32. HAMANN A, BENECKE H, GRETEN H, MATTHAEI S: Metformin increases glucose transporter protein and gene expression in human fibroblasts. Biochem Biophys Res Comm 196:382-387, 1993
33. SARABIA V, LAM L, BURDET E, LEITER LA, KLIP A: Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest 90:1386-1395, 1992
34. KLIP A, GUMÀ A, RAMLAL T, BILAN PJ, LAM L, LEITER LA: Stimulation of glucose transport by metformin in L6 muscle cells in culture. Endocrinology 130:2535-2544, 1992
35. HUNDAL HS, RAMLAL T, REYES R, LEITER LA, KLIP A: Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131:1165-1173, 1992
36. GALUSKA D, ZIERATH J, THÖRNE A, SONNENFELD T, WALLBERG-HENRIKSSON H: Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle. Diabete Metab 17:159-163, 1991
37. DUMLER F, CORTES P: Uracil ribonucleotide metabolism in rat and human glomerular epithelial and mesangial cells. Am J Physiol 255(Cell Physiol 24):C712-C718, 1988
38. ASANO T, SHIBASAKI Y, OHNO S, TAIRA H, LIN J-L, KASUGA M, KANAZAWA Y, AKANUMA Y, TAKAKU F, OKA Y: Rabbit brain glucose transporter responds to insulin when expressed in insulin-sensitive Chinese hamster ovary cells. J Biol Chem 264:3416-3420, 1989
39. HARRISON SA, BUXTON JM, HELGERSON AL, MACDONALD RG, CHLAPOWSKI FJ, CARRUTHERS A, CZECH MP: Insulin action on activity and cell surface disposition of human HepG2 glucose transporters expressed in Chinese hamster ovary cells. J Biol Chem 265:5793-5801, 1990
40. RISER BL, CORTES P, ZHAO X, BERNSTEIN J, DUMLER F, NARINS RG: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 90:1932-1943, 1992
41. 2+ ionophore A23187 in cultured human fibroblasts. J Biol Chem 261:12060-12065, 1986
42. KEHRER JP, LEE Y-CC, SOLEM SM: Comparison of in vivo and in vitro rates of collagen synthesis in normal and damaged lung tissue. Exper Lung Res 10:187-201, 1986
43. PHAN SM, VARANI J, SMITH D: Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J Clin Invest 76:241-247, 1985
44. MUNRO HN, FLECK A: The determination of nucleic acids. Methods Biochem Anal 12:113-176, 1996
45. BASHAN N, BURDETT E, GUMÀ A, SARGEANT R, TUMIATI T, LIU L, KLIP A: Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol 264(Cell Physiol 33):C430-C440, 1993
46. ABE M, HARPEL JG, METZ CN, NUNES I, LOSKUTOFF DJ, RIFKIN DB: An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216:276-284, 1994
47. CORTES P, DUMLER F, SASTRY KSS, VERGHESE CP, LEVIN NW: Effects of early diabetes on uridine diphosphosugar synthesis in the rat renal cortex. Kidney Int 21:676-682, 1982
48. TSANEV R, MARKOV G: Substances interfering with spectrophotometric estimation of nucleic acids and their elimination by the two-wavelength method. Biochim Biophys Acta 42:442-452, 1960
49. DOI ET, SHIBATA D, MATOBA T: Modified colorimetric ninhydrin method for peptidase assay. Anal Biochem 118:173-184, 1981
50. MALOFF BL, LOCKWOOD DH: In vitro effects of a sulfonylurea on insulin action in adipocytes. J Clin Invest 68:85-90, 1981
51. MARTZ A, JO I, JUNG CY: Sulfonylurea binding to adipocyte membranes and potentiation of insulin-stimulated hexose transport. J Biol Chem 264:13672-13678, 1989
52. 3H1 myocytes. Diabetes 39:1399-1407, 1990
53. 3H-1 myocyte. Diabetes 36:1292-1296, 1987
54. FARESE RV, ISHIZUKA T, STANDAERT ML, COOPER DR: Sulfonylureas activate glucose transport and protein kinase C in rat adipocytes. Metabolism 40:196-200, 1991
55. JACOBS DB, HAYES GR, LOCKWOOD DH: In vivo effects of sulfonylurea on glucose transport and translocation of glucose transporters in adipocytes from streptozotocin-induced diabetic rats. Diabetes 38:205-211, 1989
56. BAHR M, VON HOLTEY M, MULLER G, ECKEL J: Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride. Endocrinology 136:2547-2553, 1995
57. DIMITRAKOUDIS D, RAMLAL T, RASTOGI S, VRANIC M, KLIP A: Glycemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem J 284:341-348, 1992
58. BALDWIN SA, KAN O, WHETTON AD, MARTIN S, FAWCETT HAC, FLINT J, WILDE CJ: Regulation of the glucose transporter GLUT1 in mammalian cells. Biochem Soc Trans 22:814-817, 1994
59. WIDNELL CC, BALDWIN SA, DAVIES A, MARTIN S, PASTERNAK CA: Cellular stress induces a redistribution of the glucose transporter. FASEB J 4:1634-1637, 1990
60. SHETTY M, ISMAIL-BEIGI N, LOEB JN, ISMAIL-BEIGI F: Induction of GLUT1 mRNA in response to inhibition of oxidative phosphorylation. Am J Physiol 265(Cell Physiol 34):C1224-C1229, 1993
61. MITANI Y, BEHROOZ A, DUBYAK GR, ISMAIL-BEIGI F: Stimulation of GLUT-1 glucose transporter expression in response to exposure to calcium ionophore A-23187. Am J Physiol 269(Cell Physiol 38): C1228-C1234, 1995
62. MÜLLER G, WIED S: The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetes 42:1158-1167, 1993
63. MCMAHON RJ, FROST S: Nutrient control of GLUT1 processing and turnover in 3T3-L1 adipocytes. J Biol Chem 270:12094-12099, 1995
64. BÄHR M, VON HOLTEY M, MÜLLER G, ECKEL J: Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT 1) and GLUT4 protein expression by the sulfonylurea glimcpiride. Endocrinology 136:2547-2553, 1995
65. KAISER N, SASSON S, FEENER EP, BOUKOBZA-VARDI N, HIGASHI S, MOLLER DE, DAVIDHEISER S, PRZYBYLSKI RJ, KING; GL: Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42:80-89, 1993
66. 3H1 myocytes. Effects on glucose transporter gene expression. Diabetes 41:274-285, 1992
67. ORTIZ P A, HASPEL, HC: Differential control of the functional cell surface expression and content of hexose transporter GLUT-1 by glucose and glucose metabolism in murine fibroblasts. Biochem J 295:67-72, 1993
68. HEJLIG CW, LIU Y, ENGLAND RL, FREYTAG SO, GILBERT JD, HEILIG CO, ZHU M, CONCEPCION LA, BROSIUS FC III: D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-1-sensitive glucose uptake in rat mesangial cells. Implications for diabetic nephropathy. Diabetes 46:1030-1039, 1997
69. CORTES P, ZHAO X, RISER BL, NARINS RG: Role of glomerular mechanical strain in the pathogenesis of diabetic nephropathy. Kidney Int 51:57-68, 1997
70. KITAKAWA T, MASUMI A, AKAMATSU Y: Transforming growth factor-β stimulates glucose uptake and the expression of glucose transporter mRNA in quiescent Swiss mouse 3T3 cells. J Biol Chem 266:18066-18071, 1991
71. INMAN WH, COLOWICK SD: Stimulation of glucose uptake by transforming growth factor β: Evidence for the requirement of epidermal growth factor-receptor activation. Proc Natl Acad Sci USA 82:1346-1349, 1985
72. GALUSKA D, NOLTE LA, ZIERATH JR, WALLBERG-HERIKSSON H: Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM. Diabetologia 37:826-832, 1994
73. PENTIKAINEN PJ, NEUVONEN PJ, PENTTILA A: Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol 16:195-202, 1979
74. PANTEN U, BURGFELD J, GOERKE F, RENNICKE M, SCHWANSTECHER M, WALLASCH A, ZÜNKLER BJ, LENZEN S: Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem Pharmacol 38:1217-1229, 1989
75. PANTEN U, SCHWANSTECHER M, SCHWANSTECHER C: Sulfonylurea receptors and mechanism of sulfonylurea action. Exp Clin Endocrinol 104:1-9, 1996
76. + channels: Generating excitement in pancreatic β-cells. Diabetes 45:845-853, 1996
77. + channels. Science 268:372-373, 1995
78. + channels. Neuron 16:1011-1017, 1996
79. ÄMMÄLÄ C, MOORHOUSE A, GRIBBLE F, ASHFIELD R, PROKS P, SMITH PA, SAKURA H, COLES B, ASHCROFT SJH, ASHCROFT FM: Promiscuous coupling between the sulfonylurea receptor and inwardly rectifying potassium channels. Nature 379:545-548, 1996
80. ATP, channels. Diabetes 45:1439-1445, 1996
81. ASHCROFT SJH, ASHCROFT FM: The sulfonylurea receptor. Biochem Biophys Acta 1175:45-59, 1992
82. AGUILAR-BRYAN L, NICHOLS CG, WECHSLER SW, CLEMENT JP IV, BOYD AE III, GONZÄLEZ G, HERRERA-SOSA H, NGUY K, BRYAN J, NELSON DA: Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268:423-426, 1995
83. OZANNE SE, GUEST PC, HUTTON JC, HALES CN: Intracellular localization and molecular heterogeneity of the sulfonylurea receptor in insulin-secreting cells. Diabetplogia 38:277-282, 1995
84. 3H-glibenclamide in pancreatic islet cells. Diabetologia 29:259-261, 1986
85. ASANO K, CORTES P, RISER BL, RODRIGUEZ-BARBERO A, YEE J, NARINS RG: Mechanisms of sulfonylurea (SULF) action on mesangial cell matrix formation, (abstract) J Am Soc Nephrol 8:634A, 1997
86. CARPENTER A-M, GOETZ FC, LECOMPTE PM, WILLIAMSON JR: Glomerulosclerosis in type 2 (non-insulin-dependent) diabetes mellitus: Relationship to glycemia in the University Group Diabetes Program (UGDP). Diabetologia 36:1057-1063, 1993